BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg(Memorial Sloan Kettering Cancer Center), Ricky W. Johnstone(Peter MacCallum Cancer Centre)
Cited by 297
Related Papers
New and emerging HDAC inhibitors for cancer treatment
|Journal of Clinical Investigation|2014|1.4k
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
|Nature|2016|205
Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
|PLoS Biology|2010|196